Table 4. Funding and net cost of rolling out MC using the public cost model, pooled across 16 countries/settings of sub-Saharan Africa.
| Public cost model | |
| Funding (million US$) through year 5 | |
| Total (95% PI) | 919 (726 to 1 245) |
| Average per year (95% PI) | 184 (145 to 249) |
| Funding (million US$) years 6–10 | |
| Total (95% PI) | 158 (126 to 204) |
| Average per year (95% PI) | 32 (25 to 41) |
| Funding (million US$) through year 10 | |
| Total (95% PI) | 1 077 (855 to 1 448) |
| Average per year (95% PI) | 108 (86 to 145) |
| Funding (million US$) through year 20 | |
| Value (95% PI) | 1 347 (1 070 to 1 784) |
| Average per year (95% PI) | 67 (53 to 89) |
| Cost per HIV infection averted over 10 years | 338 (266 to 456) |
| Cost per HIV infection averted over 20 years | 168 (133 to 223) |
| Cumulative net cost* (95% PI) in million US$ at 10 years | 672 (437 to 1 021) |
| Cumulative net cost* (95% PI) in million US$ at 20 years | −2 274 (−3 318 to −1 416) |
PI = percentile interval.
*
Net cost is the program cost minus savings due to averted HIV medical care (million US$; 95% percentile interval in brackets). Negative value indicates net savings.